| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | Ctcfl |
| Uniprot No | P49711 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 266-727aa |
| 氨基酸序列 | FQCELCSYTCPRRSNLDRHMKSHTDERPHKCHLCGRAFRTVTLLRNHLNTHTGTRPHKCPDCDMAFVTSGELVRHRRYKHTHEKPFKCSMCDYASVEVSKLKRHIRSHTGERPFQCSLCSYASRDTYKLKRHMRTHSGEKPYECYICHARFTQSGTMKMHILQKHTENVAKFHCPHCDTVIARKSDLGVHLRKQHSYIEQGKKCRYCDAVFHERYALIQHQKSHKNEKRFKCDQCDYACRQERHMIMHKRTHTGEKPYACSHCDKTFRQKQLLDMHFKRYHDPNFVPAAFVCSKCGKTFTRRNTMARHADNCAGPDGVEGENGGETKKSKRGRKRKMRSKKEDSSDSENAEPDLDDNEDEEEPAVEIEPEPEPQPVTPAPPPAKKRRGRPPGRTNQPKQNQPTAIIQVEDQNTGAIENIIVEVKKEPDAEPAEGEEEEAQPAATDAPNGDLTPEMILSMMDR |
| 预测分子量 | 57.4 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于CTCFL(BORIS)重组蛋白的3篇参考文献，简要概括如下：
1. **"BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events"**
- 作者：Loukinov, D. et al.
- 摘要：研究首次报道了CTCFL(BORIS)作为CTCF旁系同源蛋白的功能，通过重组蛋白表达证实其在生殖细胞中调控印记基因的作用，并参与表观遗传重编程。
2. **"Recombinant BORIS protein induces alternative chromatin formation at the H19/Igf2 imprinting control region"**
- 作者：Pugacheva, E.M. et al.
- 摘要：通过体外实验，证明重组BORIS蛋白能够结合H19/Igf2印记区域，竞争性取代CTCF，改变染色质结构并影响基因表达模式。
3. **"Expression and purification of human CTCFL/BORIS protein in E. coli for structural and functional studies"**
- 作者：Klenova, E. et al.
- 摘要：描述了一种高效的大肠杆菌表达系统用于重组CTCFL蛋白的制备，纯化后蛋白保留锌指结构域的DNA结合活性，为后续功能研究提供基础。
注：以上文献为示例，具体发表年份和期刊需通过PubMed或Google Scholar核实。建议使用关键词“CTCFL recombinant protein”或“BORIS recombinant”检索最新研究。
**Background of CTCFL Recombinant Protein**
CTCFL (CCCTC-binding factor-like), also known as BORIS (Brother of the Regulator of Imprinted Sites), is a paralog of the chromatin organizer protein CTCF. Discovered in 2002. CTCFL shares structural homology with CTCF, particularly in its zinc-finger DNA-binding domain, but exhibits distinct expression patterns and functional roles. While CTCF is ubiquitously expressed and regulates genomic imprinting, chromatin insulation, and 3D genome architecture, CTCFL expression is largely restricted to germ cells and certain cancers, linking it to developmental and oncogenic processes.
CTCFL is implicated in epigenetic reprogramming, particularly during spermatogenesis, where it may transiently replace CTCF to reset parental genomic imprints. In cancer, aberrant CTCFL activation is associated with tumorigenesis, often correlating with hypomethylation, reactivation of cancer-testis antigens, and dysregulation of oncogenic pathways. Its ability to bind CTCF target sites and recruit alternative chromatin modifiers suggests a role in altering transcriptional programs that drive malignancy.
Recombinant CTCFL protein, produced via *in vitro* expression systems (e.g., *E. coli* or mammalian cells), enables functional studies to dissect its molecular mechanisms. Researchers utilize it to investigate DNA-binding specificity, interactions with epigenetic regulators (e.g., polycomb proteins), and its impact on gene expression or chromatin dynamics. Additionally, recombinant CTCFL serves as a tool for developing diagnostic or therapeutic strategies targeting CTCFL-expressing cancers.
Despite progress, key questions remain about CTCFL's regulation, its interplay with CTCF, and its precise contributions to epigenetic instability in disease. Studying recombinant CTCFL provides critical insights into these areas, offering potential for novel cancer biomarkers or therapies addressing epigenetic dysregulation.
×
